NCT01809028View on ClinicalTrials.gov

Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Pancreatic Cancer
Interventions
PROCEDURE

EUS FNA with 2 passes

biopsy with 2 passes

PROCEDURE

EUS FNA with 4 passes

biopsy with 4 passes

Trial Locations (1)

32803

Florida Hospital, Orlando

Sponsors

Lead Sponsor

AdventHealth
All Listed Sponsors
collaborator

University of Alabama at Birmingham

OTHER

lead

AdventHealth

OTHER